openPR Logo
Press release

The Life Raft Group Announces New Board Members

04-27-2021 11:03 AM CET | Health & Medicine

Press release from: The Life Raft Group

FOR IMMEDIATE RELEASE

The Life Raft Group Announces New Board Members
Expanded Board will aid in the development of new initiatives

Wayne, NJ, April 26, 2021 The Life Raft Group (LRG), a patient advocacy organization specializing in GIST (Gastrointestinal Stromal Tumor) cancer, welcomed two new members to its Board of Directors, Kay Stolzer and Dr. Monica (mOe) Anderson.

Comprised of individuals who are passionately invested in finding a cure for GIST, and to supporting and advocating for patients and caregivers, the LRG Board of Directors welcomes the newest members, and look forward to working together to fulfill their mission.

To quote Jerry Cudzil, Board President: I am excited and frankly humbled to announce the expansion of our board of directors. As our organization and our patient population grows, so does the need to continue to expand our board. It is with great excitement that I welcome Dr. Monica Anderson and Kay Stolzer to the board of the LRG.

Kay Stolzer has been very active in the LRG community as a volunteer. She currently serves as a GIST Mentor and formerly participated in the A3 Insurance Committee. Kay has extensive experience working as a business administrator. She is currently the facilitator of the LRG patient support group, “Living Well with GIST: A Monthly Support Group for Women.”

Dr. Monica, (mOe) Anderson is an inspirational leader, motivational speaker, author, podcaster, dentist, and entrepreneur. Dr. mOe has spoken at Life Raft Group events, served as a spokesperson for our holiday campaign, and was the emcee at the 2020 Women in Sarcoma Gala which honored women who have made an extraordinary impact on the lives of sarcoma patients. She has served as a board member and volunteer for several nonprofit organizations and has a wealth of knowledge as a business owner and executive of a publishing company. To learn more about Dr. Anderson, visit her website: https://drmoeanderson.com/

Both new members share a passion for supporting the mission of the LRG.

About the Life Raft Group

The Life Raft Group is a non-profit with a simple focus: to cure a form of cancer – GIST (gastrointestinal stromal tumors) – and to help those living with it until then. Our mission is to enhance survival and quality of life for people living with GIST through patient-powered research, education and empowerment and global advocacy efforts.

To learn more, visit www.liferaftgroup.org

Mary Garland, Director of Communications
mgarland@liferaftgroup.org
155 US Highway 46
Suite 202
Wayne, NJ 07470
(973) 837-9092, ext. 108

The Life Raft Group is a non-profit with a simple focus: to cure a form of cancer – GIST (gastrointestinal stromal tumors) – and to help those living with it until then. Our mission is to enhance survival and quality of life for people living with GIST through patient-powered research, education and empowerment and global advocacy efforts.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Life Raft Group Announces New Board Members here

News-ID: 2275706 • Views: 265

More Releases from The Life Raft Group

The Life Raft Group, a Non-profit Supporting Patients with GIST Cancer, Announce …
Wayne, NJ, March 17, 2021- The Life Raft Group (LRG), a patient advocacy organization supporting patients with Gastrointestinal Stromal Tumor (GIST), a rare cancer, announced today the members of their 2021 Medical Advisory Board. Comprised of experts from leading academic and medical institutions around the world, the goal of the MAB is to share scientific and research expertise to provide strategic direction on LRG initiatives to ensure the survival and well-being

More Releases for GIST

Chatbot Builder Software Market to See Huge Growth by 2027 | Gist, MobileMonkey, …
Global Chatbot Builder Software Market Report 2021 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Chatbot Builder Software Market. Some of the key players profiled in the study are Tars, ChatBot, Gist, MobileMonkey,
The Life Raft Group, a Non-profit Supporting Patients with GIST Cancer, Announce …
Wayne, NJ, March 17, 2021- The Life Raft Group (LRG), a patient advocacy organization supporting patients with Gastrointestinal Stromal Tumor (GIST), a rare cancer, announced today the members of their 2021 Medical Advisory Board. Comprised of experts from leading academic and medical institutions around the world, the goal of the MAB is to share scientific and research expertise to provide strategic direction on LRG initiatives to ensure the survival and well-being
YabaLeftOnline NG Presenting the Latest Naija Gist and Nigeria Entertainment New …
YabaLeftOnline NG is a leading online platform in Nigeria that offers a wide variety of news from across the country. The platform displays Naija gist, as well as viral news in Nigeria. On YabaLeftOnline NG, its readers can check out the popular Nigerian music videos, music world’s news, and comedy skits. Whether it is Banky W’s campaign posters being destroyed in Lagos or the latest about BBNaija star Anto, the
Global Gastrointestinal Stromal Tumor Drug Market by Players, Types and Applicat …
"The Report 2018-2025 Gastrointestinal Stromal Tumor (GIST) Drug Report on Global and United States Market,Status and Forecast,by Players,Types and Applications provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Gastrointestinal Stromal Tumor (GIST) Drug Market This report studies the Gastrointestinal Stromal Tumor (GIST) Drug market status and outlook of global and United States, from angles of players, regions, product types and
Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Report 2018
In this report, the Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. The Values marked with XX is confidential data. To know more about CAGR figures fill in your information so that our business development executive can get in touch with
Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Report 2018
In this report, the Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. The Values marked with XX is confidential data. To know more about CAGR figures fill in your information so that our business development executive can get in touch with